|
Index of reports
> Cases with Neutropenia (12)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Clolar (Clofarabine) where reactions include neutropenia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Clolar side effects in 12 year old female
Reported by a physician from Argentina on 2012-05-25
Patient: 12 year old female
Reactions: Acute Lymphocytic Leukaemia, Neutropenia, Pyrexia
Adverse event resulted in: death
Drug(s) suspected as cause:
Etoposide
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-07-01
Clolar
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-07-01
Cytoxan
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-07-01
Possible Clolar side effects in male
Reported by a physician from Argentina on 2012-01-16
Patient: male
Reactions: Acute Lymphocytic Leukaemia, Neutropenia, Pyrexia
Adverse event resulted in: death
Drug(s) suspected as cause:
Clolar
Dosage: 40 mg/m2, qd
Indication: Acute Lymphocytic Leukaemia
Etoposide
Dosage: 150 mg/m2, unk
Indication: Acute Lymphocytic Leukaemia
Cyclophosphamide
Dosage: 440 mg/m2, unk
Indication: Acute Lymphocytic Leukaemia
Possible Clolar side effects in male
Reported by a physician from Argentina on 2012-01-16
Patient: male
Reactions: Acute Lymphocytic Leukaemia, Fanconi Syndrome, Pyrexia, Neutropenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 440 mg/m2, qdx5
Indication: Acute Lymphocytic Leukaemia Recurrent
Clolar
Dosage: 40 mg/m2, qdx5
Indication: Acute Lymphocytic Leukaemia Recurrent
Etoposide
Dosage: 150 mg/m2, qdx5
Indication: Acute Lymphocytic Leukaemia Recurrent
Possible Clolar side effects in male
Reported by a physician from Argentina on 2012-01-13
Patient: male
Reactions: Acute Lymphocytic Leukaemia, Fanconi Syndrome, Pyrexia, Neutropenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Clolar
Dosage: 40 mg/m2, qdx5
Indication: Acute Lymphocytic Leukaemia Recurrent
Etoposide
Dosage: 150 mg/m2, qdx5
Indication: Acute Lymphocytic Leukaemia Recurrent
Cyclophosphamide
Dosage: 440 mg/m2, qdx5
Indication: Acute Lymphocytic Leukaemia Recurrent
Possible Clolar side effects in male
Reported by a physician from Argentina on 2012-01-12
Patient: male
Reactions: Acute Lymphocytic Leukaemia, Drug Ineffective, Neutropenia, Pyrexia
Adverse event resulted in: death
Drug(s) suspected as cause:
Etoposide
Dosage: 150 mg/m2, qdx5, 1cycle
Indication: Acute Lymphocytic Leukaemia
Clolar
Dosage: 40 mg/m2, qdx5 1 cycle
Indication: Acute Lymphocytic Leukaemia
Cyclophosphamide
Dosage: 440 mg/m2, qdx5 1 cycle
Indication: Acute Lymphocytic Leukaemia
Possible Clolar side effects in female
Reported by a physician from Argentina on 2012-01-12
Patient: female
Reactions: Acute Lymphocytic Leukaemia, Neoplasm Progression, Neutropenia, Pyrexia
Adverse event resulted in: death
Drug(s) suspected as cause:
Clolar
Other drugs received by patient: Etoposide; Cyclophosphamide
Possible Clolar side effects in male
Reported by a physician from Argentina on 2012-01-12
Patient: male
Reactions: Acute Lymphocytic Leukaemia Recurrent, Neutropenia, Pyrexia, Rash Pruritic
Adverse event resulted in: death
Drug(s) suspected as cause:
Clolar
Dosage: 40 mg/m2, qdx5 (1 cycle)
Clolar
Dosage: 40 mg/m2, 1 cycle
Indication: Acute Lymphocytic Leukaemia Recurrent
Other drugs received by patient: Etoposide; Cyclophosphamide
Possible Clolar side effects in 17 year old male
Reported by a physician from Argentina on 2011-12-01
Patient: 17 year old male
Reactions: Grand MAL Convulsion, Sepsis, Neutropenia, Status Epilepticus, Erythema
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 440 mg/m2, qdx5
Indication: Acute Lymphocytic Leukaemia Recurrent
Start date: 2011-10-24
End date: 2011-10-28
Clolar
Dosage: 40 mg/m2, qdx5
Indication: Acute Lymphocytic Leukaemia Recurrent
Start date: 2011-10-24
End date: 2011-10-28
Etoposide
Dosage: 100 mg/m2, qdx5
Indication: Acute Lymphocytic Leukaemia Recurrent
Start date: 2011-10-24
End date: 2011-10-28
Other drugs received by patient: Acetaminophen; Benadryl
Possible Clolar side effects in 17 year old male
Reported by a physician from Argentina on 2011-11-09
Patient: 17 year old male
Reactions: Grand MAL Convulsion, Status Epilepticus, Neutropenia, Erythema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: unk
Indication: Acute Lymphocytic Leukaemia Recurrent
Clolar
Dosage: 40 mg/m2, unk
Indication: Acute Lymphocytic Leukaemia Recurrent
Start date: 2011-10-24
End date: 2011-10-28
Etoposide
Dosage: unk
Indication: Acute Lymphocytic Leukaemia Recurrent
Other drugs received by patient: Benadryl; Paracetamol
Possible Clolar side effects in 9 year old female
Reported by a physician from Argentina on 2011-10-18
Patient: 9 year old female
Reactions: Acute Lymphocytic Leukaemia, Neutropenia, Haematotoxicity, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Etoposide
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-03-29
Clolar
Dosage: 40 mg/m2 x 5, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-03-29
Cyclophosphamide
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-03-29
Possible Clolar side effects in 10 month old female
Reported by a physician from Argentina on 2011-10-18
Patient: 10 month old female
Reactions: Acute Lymphocytic Leukaemia, Neutropenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Clolar
Dosage: 40 mg/m2 x 5, unk
Indication: Acute Lymphocytic Leukaemia Recurrent
Start date: 2011-02-05
Cyclophosphamide
Dosage: unk
Indication: Acute Lymphocytic Leukaemia Recurrent
Start date: 2011-02-05
Etoposide
Dosage: unk
Indication: Acute Lymphocytic Leukaemia Recurrent
Start date: 2011-02-05
Possible Clolar side effects in 5 year old female
Reported by a consumer/non-health professional from Argentina on 2011-10-17
Patient: 5 year old female
Reactions: Acute Lymphocytic Leukaemia, Neutropenia, Haematotoxicity
Adverse event resulted in: death
Drug(s) suspected as cause:
Etoposide
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Cyclophosphamide
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Clolar
Dosage: 40 mg/m2, qdx5
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-12-02
|
